"SARS-CoV-2/COVID-19 Two Years After: Current Topics" ed. by Alfonso J. Rodriguez-Morales

This book presents a selection of the last two years’ learning from research and clinical practice concerning SARS-CoV-2/COVID-19.

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has probably been the most important disease to emerge in the 21st century. This viral zoonotic disease has been a significant cause of morbidity and mortality worldwide, but with a higher impact in low- and middle-income countries of Africa, Asia, and Latin America. Up to December 4, 2022, more than 645,195,564 cases had been reported globally, with 6,640,845 deaths, and more than 13,054,668,703 doses of a vaccine had been given. Research has been of the utmost importance in the COVID-19 crisis: a great deal of knowledge was gathered between December 2019 and December 2022. Appropriate evidence-based management and the development of safe and effective vaccines have been key to controlling the virus.

Contents
1. Lessons from SARS-CoV-2/COVID-19 after Two Years of Pandemic
2. Analysis of SARS-CoV-2 Indirect Spreading Routes and Possible Countermeasures
3. COVID-19 behind Ground Glasses
4. SARS-CoV-2 Variants – Two Years Post-Onset of the Pandemic
5. SARS-CoV-2 Mutation Mechanism, Features, and Future Perspective
6. Panama: Scope and Psychosocial Challenges Two Years after the COVID-19 Pandemic
7. Emerging SARS-CoV-2 Variants of Concern (VOCs) and Their Impact on Transmission Rate, Disease Severity and Breakthrough Infections
8. SARS-CoV-2 Variant Surveillance in Genomic Medicine Era
9. Advances in Diagnosis and Treatment for SARS-CoV-2 Variants
10. Novel Diagnostics Methods for SARS-CoV-2
11. Microfluidic Technologies for On-Site Detection and Quantification of Infectious Diseases – The Experience with SARS-CoV-2/COVID-19
12. Recent Progressions on the Colorimetric Diagnosis of SARS-CoV-2 by Loop-Mediated Isothermal Amplification (LAMP) Assay
13. Bioinformatics Study of the Evolution of SARS-CoV-2 Spike Protein
14. Real-Time Genomic Surveillance for SARS-CoV-2 on Center Stage
15. Emergency COVID-19 Guidelines Impacts on the Human Microbiome and Immune System
16. Ethics of Using Placebo Controlled Trials for Covid-19 Vaccine Development in Vulnerable Populations
17. Tracking Trails of SARS CoV-2 – Variants to Therapy
18. SARS-COV-2 Pandemic: How to Maintain a COVID-free Hospital


More : You find here